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Abstract
Background: Early treatment with rt-PA is critical for favorable outcome of acute stroke. However, only a very small
proportion of stroke patients receive this treatment, as most arrive at hospital too late to be eligible for rt-PA therapy.
Methods and Findings: We developed a ‘‘Mobile Stroke Unit’’, consisting of an ambulance equipped with computed
tomography, a point-of-care laboratory system for complete stroke laboratory work-up, and telemedicine capabilities for
contact with hospital experts, to achieve delivery of etiology-specific and guideline-adherent stroke treatment at the site of
the emergency, well before arrival at the hospital. In a departure from current practice, stroke patients could be differentially
treated according to their ischemic or hemorrhagic etiology even in the prehospital phase of stroke management.
Immediate diagnosis of cerebral ischemia and exclusion of thrombolysis contraindications enabled us to perform
prehospital rt-PA thrombolysis as bridging to later intra-arterial recanalization in one patient. In a complementary patient
with cerebral hemorrhage, prehospital diagnosis allowed immediate initiation of hemorrhage-specific blood pressure
management and telemedicine consultation regarding surgery. Call-to-therapy-decision times were 35 minutes.
Conclusion: This preliminary study proves the feasibility of guideline-adherent, etiology-specific and causal treatment of
acute stroke directly at the emergency site.
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Introduction
Stroke is the main cause of chronic disability in adults and a
major cause of death and dementia [1,2]. Recanalization of
occluded arteries by systemic thrombolysis with recombinant tissue
plasminogen activator (rt-PA) within 3 hours after onset of
ischemic stroke significantly reduces disability and death [3–5].
However, before administration of rt-PA therapy, neurological
examination, imaging, and laboratory analyses are required to
exclude hemorrhagic stroke, stroke mimics or other contraindica-
tions for thrombolysis [4–7]. Consequently, implementation of rt-
PA therapy within the narrow therapeutic window is difficult to
achieve in clinical routine. Despite the potential for thrombolytic
therapy to improve the outcomes of patients after ischemic stroke,
only 15–40% arrive at the hospital early enough to be eligible for
treatment [8,9]. Thus, studies have estimated that only 1.8%–
3.0% of all ischemic stroke patients in the United States are treated
with rt-PA [10,11].
Acute stroke management needs to be reconfigured to allow
rapid screening and treatment of stroke patients for time-limited
therapy. To accomplish this, we realized a specialized ambulance,
Mobile Stoke Unit (MSU, ‘‘Stroke-Ambulance’’) for prehospital
stroke treatment that provides all diagnostic tools and stroke
medicine competence needed for therapeutic decisions directly at
the site of the emergency as hypothesized before [12]. Here, we
present first patients demonstrating that guideline-adherent and
etiology-specific treatment of ischemic and of hemorrhagic stroke,
as early as the prehospital phase of stroke management is feasible
in clinical reality.
Results
Patient with prehospitally treated ischemic stroke
A 66-year-old right-handed woman (case 23 of the current
MSU program and the first patient with thrombolysis bridging
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examination, the patient was awake, exhibiting a fixed ocular
deviation to the left, a very severe dysarthria, a severe right-facial
paresis and a paresis of the right upper (grade 0-1/5) and lower
(grade 2/5) extremities (NIHSS: 16, Rankin: 5, Barthel: 0).
Prehospital point-of-care-based laboratory analysis values are
shown at table 1. The prehospital CT excluded a hemorrhage,
demarcated infarction or other pathological findings, but showed a
left ‘‘hyperdense middle cerebral artery’’-sign (Fig. 1A, arrow),
indicative of a vessel occlusion [13]. Prehospitally, acute cerebral
ischemia was diagnosed. The stroke physician contacted hospital
neurologists and neuroradiologists to arrange bridging [14] to later
intra-arterial recanalization. Based on the patient’s weight of
70 kg, the total rt-PA dosage (0.9 mg/kg body weight) was
determined to be 63 mg [3,7]. Prehospital IV-thrombolysis was
started with a 6 mg rt-PA bolus, followed by infusion of further
47 mg, with plans to save 10 mg for later intra-arterial
thrombolysis, if necessary. Systolic blood pressure was closely
monitored. After IV thrombolysis, the dysarthria and paresis of the
lower extremity (grade 2-3/5) slightly improved.
At the hospital, a CT angiography and a digital subtraction
angiography confirmed an obstruction in the proximal segment of
the left middle cerebral artery (Fig. 1B) that was reopened by
consecutive mechanical recanalization [15] and intra-arterial
thrombolysis (Fig. 1C). The neurological symptoms markedly
improved until discharge at day 9 to an only slight dysarthria, a
minor facial paresis (NIHSS: 2; Rankin: 1; Barthel: 80). The MRI
at day 7 showed the residual basal ganglia infarction at the left
hemisphere (Fig. 1D). A cardioembolic etiology was diagnosed
based on the detection of a previously unknown atrial fibrillation.
Patient with prehospitally treated hemorrhagic stroke
A 63-year-old right-handed woman (case 2 of the program, first
case of cerebral hemorrhage) suddenly developed slurred speech,
drooling and left hemiparesis. The prehospital neurological status
by the stroke physician revealed a severe dysarthria, a left-sided
facial paresis and a paresis of the left upper (grade 2/5) and lower
(grade 3/5) extremities (NIHSS 7, Rankin 4, Barthel 50). Further
history by relatives revealed presence of hypertension. Complete
prehospital point-of-care-based laboratory analysis is shown at
table 1. Prehospital CT revealed an extensive intracerebral
hemorrhage in the right basal ganglia with rupture into the
ventricles (Fig. 1E). Systolic hypertension of 200 mmHg was
prehospitally adjusted with IV urapidil to 150 mmHg and
monitored every 5 minutes. CT scans were transmitted to the
hospital to inform neuroradiologists and neurosurgeons, thereby
accelerating a decision against need of acute surgical interventions
(e.g., ventricular catheter).
In the hospital, the patient markedly improved and was
discharged at home at day 38 with a residual mild left-sided
facial paresis and latent paresis of the left upper (grade 5-/5) and
lower (grade 5-/5) extremities (NIHSS: 3, Rankin: 3, Barthel: 60).
Follow-up CT at day 24 shows the residual lesion (Fig. 1F). Based
on the history of hypertension and the further work-up a
hypertensive intracerebral hemorrhage was diagnosed.
Response times
For patient 1, an overall call-to-therapy decision time of 35
minutes was achieved. Specifically, the symptom-onset-to-call time
was 25 minutes; the call-to-MSU-arrival time, 20 minutes
(distance of 12 km); the call-to-door time, 65 minutes; the MSU-
arrival-to-door time, 45 minutes; the call-to-neurological exami-
nation time, 25 minutes; the call-to-laboratory examination time,
34 minutes; and the call-to-CT time, 35 minutes.
For patient 2, an overall call-to-therapy decision time of 33
minutes was reached. The symptom-onset-to-call time was 17
minutes; the call-to-MSU-arrival time, 11 minutes (distance of
4.5 km); the call-to-door time, 63 minutes; the MSU-arrival-to-
door time, 52 minutes, the call-to-neurological examination time,
18 minutes; the call-to-laboratory examination time, 31 minutes;
and the call-to-CT time, 33 minutes.
Methods
In the context of a long-term monocentric randomised clinical
trial (ClinicalTrial.gov.Identifier: NCT00792220) started in 2009
with an expected end not before 2013, we analyzed the feasibility in
clinical practice of a unique healthcare-delivery system for provision
of prehospital treatment to acute stroke patients. The MSU
program has been integrated into the emergency medical chain in
a mixed urban and rural setting 20 km around the University
hospital, Homburg,Saarland, Germany.Ourhospital strokeservice
admits patients from a core region with a radius of approx. 16 km
(150.000 inhabitants), although this major stroke service treats, in
addition, patients beyond this core region on an irregular basis. In
2009, 804 stroke patients were admitted; of these 10.5% obtained
thrombolysis, with call-to-door time of 44614 minutes, ambulance-
arrival-to-door time of 37613 minutes, followed by an intrahospital
door-to-needle time of 59637 minutes.
The emergency medical system dispatch centre screens
potential stroke cases using a modified Rosier questionnaire
[16], and when appropriate, dispatches the MSU together with the
standard emergency support system, which in Germany includes
an emergency physician for critically ill cases. The MSU program
was approved by the Regional Ethics Committee of the ‘‘Medical
Association’’ of the Saarland, Germany. The patients described in
this manuscript have given written informed consent to publica-
tion of their case details.
The MSU system includes a paramedic, a physician trained in
stroke medicine, and a neuroradiologist (optional for this pilot
phase, as there is also telemedicine contact to a hospital
neuroradiologist). The MSU (Fig. 2A-C) is an ambulance
(Mercedes-Benz Vario 815D) that includes, apart from the
conventional ambulance equipment, an accumulator-driven and
lead-shielded CT (Tomoscan M, Philips), a telemedicine system
(Meytec Inc. Werneuchen, Germany) enabling transmission of
‘‘digital imaging and communication’’ data from CT scans or real-
time video of clinical examination of patients via UMTS, i.e., high
speed downlink packet access or alternative network standards to
the ‘‘picture archiving and communication system’’ of the hospital,
and a point-of-care laboratory system. With the latter, platelet
count, leukocyte count, erythrocyte count, hemoglobin and
hematocrit (PocH 100i, Sysmex, Hamburg, Germany), interna-
tional normalized ratio and activated partial thromboplastin time
(Hemochron Jr., ITC, Edison, NY, USA) and c-glutamyltransfer-
ase, p-amylase and glucose (Reflotron plus, Roche Diagnostics
Mannheim, Germany) are quantified as requested by current
stroke management guidelines [4,5,7].
Discussion
Although IV thrombolysis with rt-PA, initiated within 3 hours
after the onset of symptoms, is the only medical therapy currently
approved for acute ischemic stroke [4,5] this therapy is
disappointingly underused [8,9]. Here we report etiology-specific
and causal treatment of acute stroke, i.e., cerebral ischemia and
cerebral hemorrhage, directly at the site of the emergency rather
than waiting until hospital arrival. This was accomplished by a
newly developed strategy to deliver time-dependent treatment at
Mobile Stroke Unit
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13758the prehospital phase of stroke management, using an ambulance
with integrated CT, rapid point-of-care laboratory system and
telemedicine capabilities.
The two reported complementary stroke cases, one with
cerebral ischemia, the other with cerebral hemorrhage illustrate
the broad range of medical solutions made available by use of the
MSU. The MSU is not limited to the delivery of prehospital
thrombolysis; as the name implies the MSU encompasses all major
aspects of prehospital stroke medicine such as prehospital
organization of bridging to intra-arterial recanalization [14],
prehospital inquiry regarding the need for surgical or other
intervention with hospital experts via telemedicine, guideline-
adherent and etiology-specific prehospital management of phys-
iological variables (i.e., blood pressure), and prehospital decision-
making about the target hospital (e.g., a more distant hospital with
stroke unit, neurosurgery or neuroradiology vs. a closer hospital
without those resources).
The immediate diagnosis of intracerebral hemorrhage in patient
2 enabled for the first time guideline-adherent differential blood
pressure management [17,18] within the prehospital stage of
stroke management. Guidelines on blood pressure are different for
ischemia (tolerating systolic values up to 185–220 mm Hg to
enhance cerebral perfusion pressure) [4,5] compared to hemor-
rhage (intervening at systolic values of 160–180 mm Hg to avoid
ongoing bleeding [17,18], although there is, at present, less
evidence for clinical relevance of hyperacute blood pressure
reduction in hemorrhagic stroke than for hyperacute thrombolysis
in ischemic stroke.
Strong pathophysiological and clinical evidence suggests that
time gain translates to better clinical outcome in treatment of
stroke (‘‘time is brain’’ concept) [19–20]. In each of the two cases,
call-to-therapy-decision times were approximately 35 minutes, and
Figure 1. Brain imaging in prehospitally treated stroke patients. Patient with ischemic stroke: Prehospital CT excluded contraindications for
thrombolysis as a precondition for prehospital rt-PA thrombolysis (A). The ‘‘hyperdense middle cerebral artery’’ sign (arrow) suggested middle
cerebral artery occlusion that was later confirmed in hospital by angiography (B), and reopened by intraarterial recanaliziation (C). Diffusion-weighted
magnetic resonance imaging at day 7 showed the residual infarction (D). Patient with hemorrhagic stroke: Prehospital CT scan allowed immediate
diagnosis of intracerebral hemorrhage with ventricular extension (E), as a precondition for prehospital differential blood pressure management and
telemedicine consultation with hospital experts. CT performed at day 24 shows the residual lesion (F).
doi:10.1371/journal.pone.0013758.g001
Table 1. Point-of-care-laboratory examination in patients
with prehospital stroke treatment.
Laboratory test Unit Patient 1 Patient 2
leukocytes 10
3/ml 8.0 5.3
platelets 10
3/ml 280 134
erythrocytes 10
6/ml 5.36 4.19
hemoglobin g/dl 16.0 13.4
hematocrit % 47 42
INR 1.3 1.2
aPTT seconds 46* 32
p-amylase U/ml 23 160
c-glutamyltransferase U/ml 25.1 92.0
glucose mg% 99 75
*normal aPTT values for Hemochron Jr. ITC Edison, USA below 42 seconds.
doi:10.1371/journal.pone.0013758.t001
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current time limits for stroke management, i.e., the door-to-
therapy-decision times of 60 minutes defined as a goal by current
guidelines [4,5] or the .60-minute times encountered in daily
clinical practice [21]. The marked time gains reported here
resulted not only from reduced times spent in transport or
diagnostic work-ups, but also from increased efficiency in crucial
interfaces between paramedics, emergency physicians, neurolo-
gists, neuroradiologists, neurosurgeons, or laboratory personnel. If
the patient is not in a critical condition, as judged by the physician,
a potential delay in the time to hospital arrival should no longer be
crucial once the time-dependent, guideline-adherent diagnostic
work-up and therapy have already been delivered in the field.
Concerning the point-of-care laboratory system, we performed
earlier investigations showing generally good agreement between
values derived from a point-of-care laboratory and from a
centralized hospital laboratory, although room for some technical
improvement exists, i.e., of aPTT and INR. From a technical
point of view, we observed that the various components of the
MSU functioned as expected, although we initially encountered
technical problems with the CT at extreme temperatures.
Treating acute stroke immediately at the site where the patient
is found has the potential to prevent brain damage, thereby
reducing individual suffering and costs for stroke care for years and
decades. In the future, such MSU can be miniaturized, i.e., using a
smaller CT already commercially available, and could include
future diagnostic and therapeutic tools (e.g., biomarkers, sono-
thrombolysis, neuroprotectives or hemorrhage treatments, if
proven to be relevant [22]). Though large randomized multi-
center studies are needed to conclusively establish the benefit and
to determine the optimal setting (rural vs. urban), the optimal
integration in the regional emergency chain (e.g., dispatching the
MSU ambulance alone rather than combined with the conven-
tional ambulance in selected cases), and the cost effectiveness of
this MSU concept, this preliminary report demonstrates for the
first time that delivery of guideline-adherent and etiology-specific
treatment in the prehospital phase of stroke is feasible in clinical
practice.
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